Biphenyl-4-yl(4-(cyclopentanecarbonyl)piperazin-1-yl)methanone

ID: ALA4458935

PubChem CID: 38390838

Max Phase: Preclinical

Molecular Formula: C23H26N2O2

Molecular Weight: 362.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(-c2ccccc2)cc1)N1CCN(C(=O)C2CCCC2)CC1

Standard InChI:  InChI=1S/C23H26N2O2/c26-22(20-8-4-5-9-20)24-14-16-25(17-15-24)23(27)21-12-10-19(11-13-21)18-6-2-1-3-7-18/h1-3,6-7,10-13,20H,4-5,8-9,14-17H2

Standard InChI Key:  GHKFKKPHPJJMCI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   28.5645   -3.6856    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.5645   -4.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2698   -4.9073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9751   -4.5028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9751   -3.6856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2698   -3.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6822   -4.9124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6810   -5.7296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3905   -4.5049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0960   -4.9154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8038   -4.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8054   -3.6904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0933   -3.2809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3884   -3.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5132   -3.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2197   -3.6932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9270   -3.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9275   -2.4673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2149   -2.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5105   -2.4690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8556   -3.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8533   -2.4619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.1515   -4.5070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1491   -3.6855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3671   -3.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8862   -4.0999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3710   -4.7630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 21 22  2  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
 24 23  1  0
M  END

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.47Molecular Weight (Monoisotopic): 362.1994AlogP: 3.83#Rotatable Bonds: 3
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.83Np Likeness Score: -1.07

References

1. Martin MW, Lancia DR, Li H, Schiller SER, Toms AV, Wang Z, Bair KW, Castro J, Fessler S, Gotur D, Hubbs SE, Kauffman GS, Kershaw M, Luke GP, McKinnon C, Yao L, Lu W, Millan DS..  (2019)  Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).,  29  (8): [PMID:30803804] [10.1016/j.bmcl.2019.02.012]

Source